Public Health Implications for Adequate Transitional Care for HIV-infected Prisoners: Five Essential Components

Overview

Journal Clin Infect Dis

Publisher Oxford University Press

Specialty Infectious Diseases

Date 2011 Aug 17

PMID 21844030

Citations 99

Authors

Sandra A Springer

Anne C Spaulding

Jaimie P Meyer

Frederick L Altice

Affiliations

Soon will be listed here.

Abstract

In the United States, 10 million inmates are released every year, and human immunodeficiency virus (HIV) infection and acquired immunodeficiency syndrome (AIDS) prevalence is several-fold greater in criminal justice populations than in the community. Few effective linkage-to-the-community programs are currently available for prisoners infected with HIV. As a result, combination antiretroviral therapy (cART) is seldom continued after release, and virological and immunological outcomes worsen. Poor HIV treatment outcomes result from a myriad of obstacles that released prisoners face upon reentering the community, including homelessness, lack of medical insurance, relapse to drug and alcohol use, and mental illness. This article will focus on 5 distinct factors that contribute significantly to treatment outcomes for released prisoners infected with HIV and have profound individual and public health implications: (1) adaptation of case management services to facilitate linkage to care; (2) continuity of cART; (3) treatment of substance use disorders; (4) continuity of mental illness treatment; and (5) reducing HIV-associated risk-taking behaviors as part of secondary prevention.

Citing Articles

The relationship between reincarceration and treatment of opioid use disorder with extended-release naltrexone among persons with HIV.

Parchinski K, Di Paola A, Wilson A, Springer S Drug Alcohol Depend Rep. 2023; 7:100159.

PMID: 37159815 PMC: 10163604. DOI: 10.1016/j.dadr.2023.100159.

Hepatitis C virus (HCV) care in Canadian correctional facilities: Where are we and where do we need to be?.

Kronfli N, Buxton J, Jennings L, Kouyoumdjian F, Wong A Can Liver J. 2022; 2(4):171-183.

PMID: 35992759 PMC: 9202815. DOI: 10.3138/canlivj.2019-0007.

Interventions Designed to Improve HIV Continuum of Care Outcomes for Persons with HIV in Contact with the Carceral System in the USA.

Dauria E, Kulkarni P, Clemenzi-Allen A, Brinkley-Rubinstein L, Beckwith C Curr HIV/AIDS Rep. 2022; 19(4):281-291.

PMID: 35674879 PMC: 9175158. DOI: 10.1007/s11904-022-00609-x.

The health of detainees and the role of primary care: Position paper of the European Forum for Primary Care.

Groenewegen P, Dirkzwager A, van Dam A, Massalimova D, Sirdifield C, Smith L Prim Health Care Res Dev. 2022; 23:e29.

PMID: 35574709 PMC: 9112672. DOI: 10.1017/S1463423622000184.

Study protocol of a randomized controlled trial comparing two linkage models for HIV prevention and treatment in justice-involved persons.

Springer S, Nijhawan A, Knight K, Kuo I, Di Paola A, Schlossberg E BMC Infect Dis. 2022; 22(1):380.

PMID: 35428213 PMC: 9013109. DOI: 10.1186/s12879-022-07354-x.

References

Arriola K, Braithwaite R, Kennedy S, Hammett T, TINSLEY M, Wood P . A collaborative effort to enhance HIV/STI screening in five county jails. Public Health Rep. 2002; 116(6):520-9. PMC: 1497374. DOI: 10.1093/phr/116.6.520. View

Richie B, Freudenberg N, Page J . Reintegrating women leaving jail into urban communities: a description of a model program. J Urban Health. 2001; 78(2):290-303. PMC: 3456359. DOI: 10.1093/jurban/78.2.290. View

Kavasery R, Maru D, Cornman-Homonoff J, Sylla L, Smith D, Altice F . Routine opt-out HIV testing strategies in a female jail setting: a prospective controlled trial. PLoS One. 2009; 4(11):e7648. PMC: 2777332. DOI: 10.1371/journal.pone.0007648. View

Springer S, Azar M, Altice F . HIV, alcohol dependence, and the criminal justice system: a review and call for evidence-based treatment for released prisoners. Am J Drug Alcohol Abuse. 2010; 37(1):12-21. PMC: 3070290. DOI: 10.3109/00952990.2010.540280. View

Azar M, Springer S, Meyer J, Altice F . A systematic review of the impact of alcohol use disorders on HIV treatment outcomes, adherence to antiretroviral therapy and health care utilization. Drug Alcohol Depend. 2010; 112(3):178-93. PMC: 2997193. DOI: 10.1016/j.drugalcdep.2010.06.014. View

Spaulding A, Seals R, Page M, Brzozowski A, Rhodes W, Hammett T . HIV/AIDS among inmates of and releasees from US correctional facilities, 2006: declining share of epidemic but persistent public health opportunity. PLoS One. 2009; 4(11):e7558. PMC: 2771281. DOI: 10.1371/journal.pone.0007558. View

Zaller N, Holmes L, Dyl A, Mitty J, Beckwith C, Flanigan T . Linkage to treatment and supportive services among HIV-positive ex-offenders in Project Bridge. J Health Care Poor Underserved. 2008; 19(2):522-31. DOI: 10.1353/hpu.0.0030. View

Parsons J, Golub S, Rosof E, Holder C . Motivational interviewing and cognitive-behavioral intervention to improve HIV medication adherence among hazardous drinkers: a randomized controlled trial. J Acquir Immune Defic Syndr. 2007; 46(4):443-50. PMC: 2666542. DOI: 10.1097/qai.0b013e318158a461. View

Fisher J, Bang H, Kapiga S . The association between HIV infection and alcohol use: a systematic review and meta-analysis of African studies. Sex Transm Dis. 2007; 34(11):856-63. DOI: 10.1097/OLQ.0b013e318067b4fd. View

10.

Wohl D, Scheyett A, Golin C, White B, Matuszewski J, Bowling M . Intensive case management before and after prison release is no more effective than comprehensive pre-release discharge planning in linking HIV-infected prisoners to care: a randomized trial. AIDS Behav. 2010; 15(2):356-64. PMC: 3532052. DOI: 10.1007/s10461-010-9843-4. View

11.

Maru D, Bruce R, Walton M, Springer S, Altice F . Persistence of virological benefits following directly administered antiretroviral therapy among drug users: results from a randomized controlled trial. J Acquir Immune Defic Syndr. 2009; 50(2):176-81. PMC: 2670996. DOI: 10.1097/QAI.0b013e3181938e7e. View

12.

Tomasino V, SWANSON A, Nolan J, Shuman H . The Key Extended Entry Program (KEEP): a methadone treatment program for opiate-dependent inmates. Mt Sinai J Med. 2001; 68(1):14-20. View

13.

Springer S, Pesanti E, Hodges J, Macura T, Doros G, Altice F . Effectiveness of antiretroviral therapy among HIV-infected prisoners: reincarceration and the lack of sustained benefit after release to the community. Clin Infect Dis. 2004; 38(12):1754-60. DOI: 10.1086/421392. View

14.

Springer S . Improving healthcare for incarcerated women. J Womens Health (Larchmt). 2010; 19(1):13-5. PMC: 2828190. DOI: 10.1089/jwh.2009.1786. View

15.

Copenhaver M, Lee I, Margolin A, Bruce R, Altice F . Testing an optimized community-based human immunodeficiency virus (HIV) risk reduction and antiretroviral adherence intervention for HIV-infected injection drug users. Subst Abus. 2011; 32(1):16-26. PMC: 3071583. DOI: 10.1080/08897077.2011.540466. View

16.

Rosen D, Schoenbach V, Wohl D . All-cause and cause-specific mortality among men released from state prison, 1980-2005. Am J Public Health. 2008; 98(12):2278-84. PMC: 2636544. DOI: 10.2105/AJPH.2007.121855. View

17.

Kavasery R, Maru D, Sylla L, Smith D, Altice F . A prospective controlled trial of routine opt-out HIV testing in a men's jail. PLoS One. 2009; 4(11):e8056. PMC: 2777336. DOI: 10.1371/journal.pone.0008056. View

18.

Safren S, Wingood G, Altice F . Strategies for primary HIV prevention that target behavioral change. Clin Infect Dis. 2008; 45 Suppl 4:S300-307. DOI: 10.1086/522554. View

19.

Rosen M, Dieckhaus K, McMahon T, Valdes B, Petry N, Cramer J . Improved adherence with contingency management. AIDS Patient Care STDS. 2007; 21(1):30-40. DOI: 10.1089/apc.2006.0028. View

20.

Grant R, Lama J, Anderson P, McMahan V, Liu A, Vargas L . Preexposure chemoprophylaxis for HIV prevention in men who have sex with men. N Engl J Med. 2010; 363(27):2587-99. PMC: 3079639. DOI: 10.1056/NEJMoa1011205. View